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THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-
SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE 
EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
QUESTIONNAIRE, QLQ-C30 
 
Madeleine T King, DCo, NA, JB,  DCe, PF, JP, SPe, SPi, DR, GV, TY, on behalf of 
the MAUCa Consortium 
 
Objectives: Preference-based measures have been derived from various descriptive 
HRQOL measures. A general 2-stage method has evolved: 1) an item from each domain 
of the HRQOL measure is selected to form a health state classification system (HSCS); 2) 
a sample of health states is valued and an algorithm derived for estimating the utility of 
all possible health states.  The outputs of these two stages represent a MAUI. Our aim 
was to adapt the first stage for the widely-used cancer-specific QLQ-C30, and apply it to 
a large, heterogeneous, international dataset as the first step in developing an 
internationally-valid cancer-specific MAUI.  
 
Methods: Secondary analyses were conducted on a pooled dataset comprising QLQ-C30 
responses plus demographic and clinical data from 2616 patients from eight countries, 
over 14 cancer sites, all stages, and all common cancer treatments.  The established 
domain structure of the QLQ-C30 (physical, role, emotional, social and cognitive 
functioning, plus several symptoms) formed the underlying conceptual model for the 
MAUI. Generalisability of the conceptual model across cancer sites was tested with 
multi-group CFA.  Items within each domain were then subjected to statistical scrutiny, 
including Rasch analysis for domains with sufficient items. 
 
Results: CFA results supported the proposed conceptual model and its generalisability 
across cancer sites.  Two items exhibited floor effects (>75% observations at lowest 
score), none exhibited misfit to the Rasch model, one exhibited disordered item response 
thresholds, and two exhibited differential item function by cancer site.  These results, 
along with results for responsiveness and qualitative patient input (analyses underway) 
will be presented.   
 
Conclusions: The next stage of this research will obtain valuations for a range of health 
states defined by the HSCS from general population samples in various countries. The 
ability to determine a preference-based utility score from QLQ-C30 responses will 
facilitate cost-utility analysis in cancer trials which use the QLQ-C30.  
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